4//SEC Filing
Orlandi Cesare 4
Accession 0000899243-19-005210
CIK 0001521036other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:15 PM ET
Size
7.4 KB
Accession
0000899243-19-005210
Insider Transaction Report
Form 4
Orlandi Cesare
Chief Medical Officer
Transactions
- Award
Common Stock
2019-02-26+13,426→ 87,115 total - Sale
Common Stock
2019-02-27$23.10/sh−3,111$71,870→ 84,004 total
Footnotes (2)
- [F1]Starting in 2019, the Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions under 10b5-1 plans. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018, to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.56 to $23.62, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
Documents
Issuer
Lantheus Holdings, Inc.
CIK 0001521036
Entity typeother
Related Parties
1- filerCIK 0001610664
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 4:15 PM ET
- Size
- 7.4 KB